Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Maja Čemažar

PhD Maja Čemažar
no.: 14575 source: ARIS

researcher – active in research organisation
(01) 587 95 44
mcemazarat signonko-i.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • French
  • Reading: Functional
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
3.01.00  Medical sciences  Microbiology and immunology   
Keywords
Experimental oncology, electroporotion, chemotherapy, radiobiology, electrochemotherapy
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
2,278.03
A''
105.15
A'
852.5
A1/2
1,238.18
CI10
6,268
CImax
450
h10
41
A1
6.47
A3
5
Data for the last 5 years (citations for the last 10 years) on April 23, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 328  10,166  7,065  21.54 
Scopus 341  12,093  8,628  25.3 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Ajda Medved  Bologna doctoral studies    55824 
2 PhD Barbara Lisec  Bologna doctoral studies  10/1/2016 - 1/13/2022  39122 
3 PhD Katarina Žnidar  Bologna doctoral studies  11/1/2014 - 10/18/2019  37534 
4 PhD Urša Lampreht Tratar  Bologna doctoral studies  10/1/2013 - 8/21/2018  36367 
5 PhD Andreja Brožič  Bologna doctoral studies  12/1/2012 - 7/13/2016  35354 
6 PhD Nataša Tešić  Bologna doctoral studies  11/1/2011 - 5/4/2015  34477 
7 PhD Boštjan Markelc  Bologna doctoral studies  10/1/2009 - 3/31/2013  32175 
8 PhD Vesna Todorović  Uniform doctoral studies  10/1/2007 - 3/31/2011  29469 
9 PhD Gregor Tevž  Uniform doctoral studies  11/1/2005 - 4/30/2009  26164 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 1992 
Master's degree  M. Sc.     SI University of Ljubljana, Faculty of Medicine 1996 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 1998 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (60%, RD:60%)  Institute of Oncology Ljubljana  Department of research  11/1/1992  Research counsellor  Researcher   
Full time employment (60%, RD:30%)  Universita del Litorale, Facolta di Scienze della Salute  Raziskovalna skupina UP FVZ (Slovene)  9/19/2005  Professor  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,193 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,904 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,833 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,084 
5. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   2023 - 2024  PhD Matej Reberšek  3,469 
6. J7-50128  Trace metals disorder as biomarker in biliary tract cancers   2023 - 2024  PhD Janez Ščančar  3,650 
7. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,470 
8. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,919 
9. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,049 
10. J7-4540  Socio-economic consequences of cancer from the perspective of the individual and society including the impact of COVID-19 pandemic   2022 - 2024  PhD Ivica Ratoša  4,718 
11. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   2022 - 2024  PhD Metka Novak  1,775 
12. BI-AT/23-24-004  The role of necroptosis in acute myeloid leukemia   2023 - 2024  PhD Maja Čemažar  1,427 
13. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   2021 - 2024  PhD Anže Smole  2,499 
14. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,770 
15. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,173 
16. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   2020 - 2023  PhD Nataša Tozon  3,556 
17. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2023  PhD Boštjan Markelc  3,338 
18. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2020 - 2023  PhD Mateja Erdani Kreft  5,131 
19. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,496 
20. N3-0059  Plasma-assisted wound treatment and topical introduction of molecules   2017 - 2020  PhD Uroš Cvelbar  3,038 
21. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2017 - 2020  PhD Janko Kos  4,553 
22. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2020  PhD Maja Čemažar  3,542 
23. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   2016 - 2019  PhD Igor Emri  4,425 
24. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,257 
25. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   2016 - 2018  PhD Mateja Erdani Kreft  7,080 
26. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2014 - 2017  PhD Metka Filipič  4,043 
27. J1-6744  Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis   2014 - 2017  PhD Tina Kosjek  4,810 
28. J1-6734  Lightweight alloys based on aluminium as materials with increasing potential in transport industry   2014 - 2017  PhD Ingrid Milošev  3,496 
29. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,092 
30. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,738 
31. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,269 
32. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2016  PhD Janko Kos  5,950 
33. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,456 
34. J1-4044  Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells   2011 - 2014  PhD Tom Turk  6,260 
35. L2-4105  Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation   2011 - 2014  PhD Damijan Miklavčič  4,817 
36. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,846 
37. J1-4131  Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors   2011 - 2014  PhD Iztok Turel  5,936 
38. J2-3639  New lipid model systems for determination of electroporation basic mechanisms   2010 - 2013  PhD Damijan Miklavčič  5,136 
39. J3-2277  Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene)   2009 - 2012  PhD Maja Čemažar  2,818 
40. J3-2218  Ugotavljanje infekcije protez pri zamenjavi umetnih sklepov (Slovene)   2009 - 2012  PhD Andrej Cör  2,900 
41. J3-0485  Antiangiogenic siRNA for the treatment of advanced malignant melanoma   2008 - 2011  PhD Maja Čemažar  2,585 
42. J3-9580  Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens   2007 - 2009  PhD Gregor Serša  2,468 
43. J7-9743  The impact of health care on the quality of life of elderly people: The influence of incontinence and impaired mobility on functionary of elderly people   2007 - 2009  PhD Maja Čemažar  2,949 
44. M1-0151  Molekularna detekcija posledic uporabe in delovanja biološkega orožja in toksinov z dolgodobnim delovanjem (Slovene)   2007 - 2008  PhD Metka Filipič  5,145 
45. J3-7044  Treatment of malignant tumours with electrogene therapy   2005 - 2008  PhD Maja Čemažar  3,351 
46. J3-6260  Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene)   2004 - 2007  PhD Marija Auersperg  4,350 
47. L3-5012  MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS   2003 - 2005  PhD Metka Ravnik-Glavač  4,639 
48. J3-4207  Ocena učinkovitosti presejanja za raka materničnega vratu v Sloveniji; študija primerov s kontrolami (Slovene)   2002 - 2005  PhD Maja Primic-Žakelj  3,170 
49. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   2002 - 2005  PhD Maja Čemažar  4,834 
50. J3-3489  New biomedical applications of electroporation   2002 - 2004  PhD Gregor Serša  4,063 
51. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   2000 - 2002  PhD Maja Čemažar  4,106 
52. J3-7843  Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene)   1996 - 2001  PhD Gregor Serša  4,128 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,946 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,264 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2009 - 2014  PhD Gregor Serša  4,018 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2004 - 2008  PhD Gregor Serša  3,076 
International projects
no. Code Title Period Head
1. COST-TD1104  COST - European Network for Development of Electroporation-based technologies and treatments EP4Bio2Med   4/10/2012 - 4/9/2016  Damijan Miklavčič   
2. INTERREG-TRANS2CARE    4/1/2011 - 9/30/2014  Maja Čemažar   
Confirmation required
Views history
Favourite